Difference between revisions of "Topiramate"

From Psychiatrienet
Jump to: navigation, search
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
{{Drug
 
{{Drug
| name = topiramate
+
| name = Topiramate
 
| group = anticonvulsant
 
| group = anticonvulsant
| otheruse = mood stabilizer
+
| type = moodstabilizer
| type = Moodstabilizer
 
 
| medscape = 14496
 
| medscape = 14496
 
| pubchem = 5284627
 
| pubchem = 5284627
Line 9: Line 8:
 
| ftk = topiramaat
 
| ftk = topiramaat
 
| ATC = N03AX11
 
| ATC = N03AX11
| metabolization = Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.
+
| metabolization = * Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.
<includeonly>
+
| administration = O
| isswitch = 1
+
| halflife = 21
</includeonly>
+
| halflife_ref = <ref name="ftk">{{FTK|topiramaat}}</ref>
 +
| bioavailability = 50
 +
| bioavailability_ref = <ref name="ftk">{{FTK|topiramaat}}</ref>
 +
| <includeonly> isswitch = 1 </includeonly>
 
}}
 
}}

Latest revision as of 00:02, 27 April 2010

Topiramate
Type moodstabilizer
Group anticonvulsant
links
ATC-code N03AX11
PubChem 5284627
PubMed Topiramate
Drugs.com topiramate
Kompas (Dutch) Topiramate
Wikipedia Topiramate

Topiramate is a moodstabilizer in the group anticonvulsant.


Metabolization
  • Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.